These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9262454)

  • 1. Pulmonary vasoreactivity to serotonin during hypoxia is modulated by ATP-sensitive potassium channels.
    Barman SA
    J Appl Physiol (1985); 1997 Aug; 83(2):569-74. PubMed ID: 9262454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channels modulate hypoxic pulmonary vasoconstriction.
    Barman SA
    Am J Physiol; 1998 Jul; 275(1):L64-70. PubMed ID: 9688936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of calcium-activated potassium channels and cyclic nucleotides on pulmonary vasoreactivity to serotonin.
    Barman SA
    Am J Physiol; 1997 Jul; 273(1 Pt 1):L142-7. PubMed ID: 9252551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channels modulate canine pulmonary vasoreactivity to protein kinase C activation.
    Barman SA
    Am J Physiol; 1999 Sep; 277(3):L558-65. PubMed ID: 10484463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels.
    Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vasoreactivity to endothelin-1 at elevated vascular tone is modulated by potassium channels.
    Barman SA
    J Appl Physiol (1985); 1996 Jan; 80(1):91-8. PubMed ID: 8847337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine pulmonary vasoreactivity to serotonin: role of protein kinase C and tyrosine kinase.
    Barman SA; Pauly JR; Isales CM
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H740-7. PubMed ID: 9124433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halothane and enflurane attenuate pulmonary vasodilation mediated by adenosine triphosphate-sensitive potassium channels compared to the conscious state.
    Seki S; Sato K; Nakayama M; Murray PA
    Anesthesiology; 1997 Apr; 86(4):923-35. PubMed ID: 9105237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of potassium channel openers on hypoxic pulmonary vasoconstriction].
    Matsumoto H; Nakano H; Akiba Y; Osanai S; Tobise K; Onodera S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1488-95. PubMed ID: 1434222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glibenclamide does not reverse attenuated vasoreactivity to acute or chronic hypoxia.
    Eichinger MR; Resta TC; Balderrama DS; Herrera GM; Richardson LA; Resta JM; Walker BR
    J Appl Physiol (1985); 1995 Oct; 79(4):1173-80. PubMed ID: 8567559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K+ATP-channel activation causes marked vasodilation in the hypertensive neonatal pig lung.
    Pinheiro JM; Malik AB
    Am J Physiol; 1992 Nov; 263(5 Pt 2):H1532-6. PubMed ID: 1443205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary and systemic haemodynamic effects of cromakalim in conditions of normoxia and hypoxia in dogs.
    Martin DJ; Gellotte M; Armstrong JM; Hicks PE
    J Auton Pharmacol; 1990 Oct; 10(5):261-72. PubMed ID: 2084109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
    Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
    J Pharmacol Exp Ther; 1990 Nov; 255(2):818-25. PubMed ID: 2123008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-sensitive K+ channels are not involved in ischemia-reperfusion lung endothelial injury.
    Khimenko PL; Moore TM; Taylor AE
    J Appl Physiol (1985); 1995 Aug; 79(2):554-9. PubMed ID: 7592217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol ester potentiation of canine pulmonary vasoreactivity to histamine.
    Barman SA; Ikeda SR
    J Appl Physiol (1985); 1995 Jul; 79(1):102-6. PubMed ID: 7559205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vascular and renal effects of cromakalim in anaesthetized dogs.
    Hicks PE; Martin D; Dumez D; Zazzi-Sudriez E; Armstrong JM
    Pflugers Arch; 1989; 414 Suppl 1():S192-3. PubMed ID: 2780259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of protein kinase C inhibition on hypoxic pulmonary vasoconstriction.
    Barman SA
    Am J Physiol Lung Cell Mol Physiol; 2001 May; 280(5):L888-95. PubMed ID: 11290512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
    Uchida W; Hirano Y; Taguchi T; Masuda N; Shirai Y; Satoh N; Takenaka T
    Eur J Pharmacol; 1994 Nov; 264(3):285-93. PubMed ID: 7698167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NO pathway, calcium and potassium channels in the peripheral pulmonary vascular tone in dogs.
    Chabot F; Schrijen F; Saunier C
    Eur Respir J; 2001 Jan; 17(1):20-6. PubMed ID: 11307749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segmental vascular resistances and compliances in dog lung.
    Rippe B; Parker JC; Townsley MI; Mortillaro NA; Taylor AE
    J Appl Physiol (1985); 1987 Mar; 62(3):1206-15. PubMed ID: 3571076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.